IDXX - IDEXX Laboratories - Stock Forecast

Healthcare - Sector
Coverage Profile Stock analysts Price Targets & Ratings Chart

IDXX is currently covered by 10 analysts with an average price target of $719.23. This is a potential upside of $29.58 (4.29%) from yesterday's end of day stock price of $689.65.

IDEXX Laboratories's activity chart (see below) currently has 265 price targets and 190 ratings on display. The stock rating distribution of IDXX is 47.83% BUY and 52.17% HOLD.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 84.22% of the time, taking 264.68 days on average.

Highest price target for IDXX is $810, Lowest price target is $640, average price target is $719.23.

Most recent stock forecast was given by ERIN WRIGHT from MORGAN STANLEY on 03-Nov-2026. First documented stock forecast 24-Jun-2014.

Overview

IDEXX Laboratories is a global leader in veterinary diagnostic testing and services, as well as water quality testing solutions. The company primarily serves the companion animal veterinary market, as well as livestock and poultry producers, dairy farmers, and the biomedical research community.

Operations

IDEXX offers a wide range of diagnostic products and services, including point-of-care veterinary diagnostic products, veterinary reference laboratory diagnostic and consulting services, and practice management and diagnostic imaging systems and services for veterinarians. The company also provides health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for the biomedical research community.

In addition to veterinary diagnostic products, IDEXX also offers diagnostic and health-monitoring products for livestock, poultry, and dairy producers. These products include water testing products that test for various microbiological contaminants, as well as point-of-care electrolytes and blood gas analyzers.

During the COVID-19 pandemic, IDEXX also developed an RT-PCR test kit for human COVID-19 testing, called OPTI SARS-CoV-2 RT-PCR test kit.

IDEXX has a broad range of testing capabilities, including in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers, as well as SNAP rapid assays test kits. The company also offers veterinary software and services for independent veterinary clinics and corporate groups.

History

The company was founded in 1983 and is headquartered in Westbrook, Maine.

Best performing analysts who are covering IDXX - IDEXX Laboratories:

Steve Chesney Balaji Prasad Chris Schott Daniel Grosslight Erin Wright Daniel Clark

Currently out of the existing stock ratings of IDXX, 11 are a BUY (47.83%), 12 are a HOLD (52.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 03-Nov-2014

$810

$105.77 (15.02%)

$805

16 days ago
(03-Nov-2026)

25/29 (86.21%)

$138.36 (20.60%)

363

Hold Since 01-Oct-2025

$700

$-4.23 (-0.60%)

$627

16 days ago
(03-Nov-2026)

7/10 (70%)

$28.36 (4.22%)

63

Buy Since 25-Jul-2024

$800

20 days ago
(30-Oct-2026)

22/25 (88%)

$167.44 (26.47%)

132

Buy Since 29-Jan-2021

$750

$45.77 (6.50%)

$775

1 months 3 days ago
(16-Oct-2026)

8/10 (80%)

$189.64 (33.84%)

446

Buy Since 09-Dec-2025

$710

$5.77 (0.82%)

$800

3 months 8 days ago
(11-Aug-2026)

0/4 (0%)

$123.36 (21.03%)

Show more analysts

Please expand the browser size to see the chart

What is IDXX (IDEXX Laboratories) average time for price targets to be met?

On average it took 265 days for the stock forecasts to be reached, with an average price target met ratio of 84.22%.

Which analyst most recently updated their price target on IDXX (IDEXX Laboratories)?

Erin Wilson

Which analyst has the most public recommendations on IDXX (IDEXX Laboratories)?

Erin Wilson works at MORGAN STANLEY and has 3 price targets and 0 ratings on IDXX

Which analyst is the currently most bullish on IDXX (IDEXX Laboratories)?

Erin Wright with the highest potential upside of $253.5

Which analyst is the currently most reserved on IDXX (IDEXX Laboratories)?

Kevin Ellich with the lowest potential downside of -$627.23
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?